{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,5]],"date-time":"2026-10-05T22:25:35Z","timestamp":1791239135371,"version":"4.1.0"},"reference-count":166,"publisher":"Public Library of Science (PLoS)","issue":"7","license":[{"start":{"date-parts":[[2019,7,11]],"date-time":"2019-07-11T00:00:00Z","timestamp":1562803200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100000781","name":"European Research Council","doi-asserted-by":"publisher","award":["639377"],"award-info":[{"award-number":["639377"]}],"id":[{"id":"10.13039\/501100000781","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["www.plosone.org"],"crossmark-restriction":false},"short-container-title":["PLoS ONE"],"DOI":"10.1371\/journal.pone.0219778","type":"journal-article","created":{"date-parts":[[2019,7,11]],"date-time":"2019-07-11T17:39:41Z","timestamp":1562866781000},"page":"e0219778","update-policy":"https:\/\/doi.org\/10.1371\/journal.pone.corrections_policy","source":"Crossref","is-referenced-by-count":36,"title":["Use and validity of child neurodevelopment outcome measures in studies on prenatal exposure to psychotropic and analgesic medications \u2013 A systematic review"],"prefix":"10.1371","volume":"14","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-2841-5868","authenticated-orcid":true,"given":"Sarah","family":"Hjorth","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rebecca","family":"Bromley","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4390-6171","authenticated-orcid":true,"given":"Eivind","family":"Ystrom","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Angela","family":"Lupattelli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Olav","family":"Spigset","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hedvig","family":"Nordeng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"340","published-online":{"date-parts":[[2019,7,11]]},"reference":[{"key":"ref1","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1002\/pds.3866","article-title":"EUROmediCAT Recommendations for European Pharmacovigilance concerning safety of medication use in pregnancy: ABSTRACT","volume":"24","year":"2015","journal-title":"Pharmacoepidemiol Drug Saf"},{"key":"ref2","doi-asserted-by":"crossref","first-page":"j3950","DOI":"10.1136\/bmj.j3950","article-title":"Prenatal exposure to antidepressants and increased risk of psychiatric disorders","author":"H Nordeng","year":"2017","journal-title":"BMJ"},{"issue":"6","key":"ref3","doi-asserted-by":"crossref","first-page":"672","DOI":"10.1038\/clpt.2009.201","article-title":"Sustained neurobehavioral effects of exposure to SSRI antidepressants during development: molecular to clinical evidence","volume":"86","author":"TF Oberlander","year":"2009","journal-title":"Clin Pharmacol Ther"},{"issue":"8","key":"ref4","doi-asserted-by":"crossref","first-page":"718","DOI":"10.1111\/dmcn.12745","article-title":"Use of paracetamol during pregnancy and child neurological development","volume":"57","author":"L de Fays","year":"2015","journal-title":"Dev Med Child Neurol"},{"issue":"3","key":"ref5","doi-asserted-by":"crossref","first-page":"208","DOI":"10.1016\/j.ajog.2014.05.040","article-title":"Developing a systematic approach to safer medication use during pregnancy: summary of a Centers for Disease Control and Prevention\u2013convened meeting","volume":"211","author":"CS Broussard","year":"2014","journal-title":"Am J Obstet Gynecol"},{"issue":"2","key":"ref6","doi-asserted-by":"crossref","first-page":"e004365","DOI":"10.1136\/bmjopen-2013-004365","article-title":"Medication use in pregnancy: a cross-sectional, multinational web-based study","volume":"4","author":"A Lupattelli","year":"2014","journal-title":"BMJ Open"},{"issue":"3","key":"ref7","doi-asserted-by":"crossref","first-page":"771","DOI":"10.1016\/j.ajog.2005.02.100","article-title":"the National Birth Defects Prevention Study. Use of over-the-counter medications during pregnancy","volume":"193","author":"MM Werler","year":"2005","journal-title":"Am J Obstet Gynecol"},{"issue":"4","key":"ref8","doi-asserted-by":"crossref","first-page":"600","DOI":"10.1111\/j.1365-2125.2007.03048.x","article-title":"Increase in use of selective serotonin reuptake inhibitors in pregnancy during the last decade, a population-based cohort study from the Netherlands","volume":"65","author":"MK Bakker","year":"2008","journal-title":"Br J Clin Pharmacol"},{"issue":"4","key":"ref9","doi-asserted-by":"crossref","first-page":"e63034","DOI":"10.1371\/journal.pone.0063034","article-title":"Prevalence of antidepressant use during pregnancy in Denmark, a nation-wide cohort study","volume":"8","author":"E Jimenez-Solem","year":"2013","journal-title":"PloS One"},{"issue":"1","key":"ref10","doi-asserted-by":"crossref","first-page":"51.e1-51","DOI":"10.1016\/j.ajog.2011.02.029","article-title":"Medication use during pregnancy, with particular focus on prescription drugs: 1976\u20132008","volume":"205","author":"AA Mitchell","year":"2011","journal-title":"Am J Obstet Gynecol"},{"issue":"8","key":"ref11","doi-asserted-by":"crossref","first-page":"826","DOI":"10.1001\/jamapsychiatry.2016.0934","article-title":"Neonatal Outcomes in Women With Untreated Antenatal Depression Compared With Women Without Depression: A Systematic Review and Meta-analysis","volume":"73","author":"A Jarde","year":"2016","journal-title":"JAMA Psychiatry"},{"issue":"5","key":"ref12","doi-asserted-by":"crossref","first-page":"e477","DOI":"10.4088\/JCP.15r10483","article-title":"A Systematized Review of Atypical Antipsychotics in Pregnant Women: Balancing Between Risks of Untreated Illness and Risks of Drug-Related Adverse Effects","volume":"78","author":"S Tosato","year":"2017","journal-title":"J Clin Psychiatry"},{"key":"ref13","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1016\/j.seizure.2016.10.006","article-title":"Fetal antiepileptic drug exposure and cognitive outcomes","volume":"44","author":"RL Bromley","year":"2017","journal-title":"Seizure"},{"key":"ref14","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1186\/1741-7015-11-126","article-title":"Toward the future of psychiatric diagnosis: the seven pillars of RDoC","volume":"11","author":"BN Cuthbert","year":"2013","journal-title":"BMC Med"},{"issue":"10","key":"ref15","doi-asserted-by":"crossref","first-page":"973","DOI":"10.1007\/s00787-014-0558-3","article-title":"Maternal use of antidepressant or anxiolytic medication during pregnancy and childhood neurodevelopmental outcomes: a systematic review","volume":"23","author":"H El Marroun","year":"2014","journal-title":"Eur Child Adolesc Psychiatry"},{"issue":"8","key":"ref16","doi-asserted-by":"crossref","first-page":"1817","DOI":"10.1093\/aje\/kwy086","article-title":"Prenatal Exposure to Acetaminophen and Risk for Attention Deficit Hyperactivity Disorder and Autistic Spectrum Disorder: A Systematic Review, Meta-Analysis, and Meta-Regression Analysis of Cohort Studies","volume":"187","author":"R Masarwa","year":"2018","journal-title":"Am J Epidemiol"},{"issue":"1","key":"ref17","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1176\/appi.ajp.2011.11010050","article-title":"DSM-5: How Reliable Is Reliable Enough?","volume":"169","author":"HC Kraemer","year":"2012","journal-title":"Am J Psychiatry"},{"key":"ref18","first-page":"96","article-title":"In: Measurement in Medicine: A Practical Guide","author":"HCW de Vet","year":"2011"},{"key":"ref19","first-page":"150","article-title":"In: Measurement in Medicine: A Practical Guide","author":"HCW de Vet","year":"2011"},{"key":"ref20","first-page":"7","article-title":"Measurement in Medicine: A Practical Guide","author":"HCW de Vet","year":"2011"},{"key":"ref21","unstructured":"WHO. WHOCC\u2014ATC\/DDD Index [Internet]. WHO Collaborating Centre for Drug Statistics Methodology. 2017 [cited 2018 Jul 6]. Available from: <ext-link xmlns:xlink=\"http:\/\/www.w3.org\/1999\/xlink\" ext-link-type=\"uri\" xlink:href=\"https:\/\/www.whocc.no\/atc_ddd_index\/\" xlink:type=\"simple\">https:\/\/www.whocc.no\/atc_ddd_index\/<\/ext-link>"},{"key":"ref22","doi-asserted-by":"crossref","DOI":"10.1002\/14651858.CD010236.pub2","article-title":"Treatment for epilepsy in pregnancy: neurodevelopmental outcomes in the child","author":"R Bromley","year":"2014"},{"issue":"7","key":"ref23","doi-asserted-by":"crossref","first-page":"e017248","DOI":"10.1136\/bmjopen-2017-017248","article-title":"Comparative safety of antiepileptic drugs for neurological development in children exposed during pregnancy and breast feeding: a systematic review and network meta-analysis","volume":"7","author":"AA Veroniki","year":"2017","journal-title":"BMJ Open"},{"key":"ref24","unstructured":"WHO. ICD-10 Version:2016 [Internet]. International Statistical Classification of Diseases and Related Health Problems 10th Revision. 2016 [cited 2017 Sep 19]. Available from: <ext-link xmlns:xlink=\"http:\/\/www.w3.org\/1999\/xlink\" ext-link-type=\"uri\" xlink:href=\"http:\/\/apps.who.int\/classifications\/icd10\/browse\/2016\/en\" xlink:type=\"simple\">http:\/\/apps.who.int\/classifications\/icd10\/browse\/2016\/en<\/ext-link>"},{"issue":"1\u20132","key":"ref25","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1016\/S0149-7634(03)00005-8","article-title":"Trajectories of brain development: point of vulnerability or window of opportunity?","volume":"27","author":"SL Andersen","year":"2003","journal-title":"Neurosci Biobehav Rev"},{"key":"ref26","unstructured":"Covidence. Covidence\u2014Accelerate your systematic review [Internet]. 2017 [cited 2017 Oct 11]. Available from: <ext-link xmlns:xlink=\"http:\/\/www.w3.org\/1999\/xlink\" ext-link-type=\"uri\" xlink:href=\"https:\/\/www.covidence.org\/\" xlink:type=\"simple\">https:\/\/www.covidence.org\/<\/ext-link>"},{"issue":"4","key":"ref27","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1016\/j.jclinepi.2010.07.017","article-title":"GRADE guidelines: 4. Rating the quality of evidence\u2014study limitations (risk of bias)","volume":"64","author":"GH Guyatt","year":"2011","journal-title":"J Clin Epidemiol"},{"issue":"4","key":"ref28","doi-asserted-by":"crossref","first-page":"539","DOI":"10.1007\/s11136-010-9606-8","article-title":"The COSMIN checklist for assessing the methodological quality of studies on measurement properties of health status measurement instruments: an international Delphi study","volume":"19","author":"LB Mokkink","year":"2010","journal-title":"Qual Life Res Int J Qual Life Asp Treat Care Rehabil"},{"issue":"12","key":"ref29","doi-asserted-by":"crossref","first-page":"1277","DOI":"10.1016\/j.jclinepi.2011.01.011","article-title":"GRADE guidelines: 5. Rating the quality of evidence\u2014publication bias","volume":"64","author":"GH Guyatt","year":"2011","journal-title":"J Clin Epidemiol"},{"key":"ref30","first-page":"567","article-title":"Statistical power analysis for the behavioral sciences","author":"J Cohen","year":"1988"},{"key":"ref31","unstructured":"Kontopantelis E, Reeves D. METAEFF: Stata module to perform effect sizes calculations for meta-analyses [Internet]. 2011 [cited 2018 Jul 6]. Available from: <ext-link xmlns:xlink=\"http:\/\/www.w3.org\/1999\/xlink\" ext-link-type=\"uri\" xlink:href=\"http:\/\/EconPapers.repec.org\/RePEc:boc:bocode:s457072\" xlink:type=\"simple\">http:\/\/EconPapers.repec.org\/RePEc:boc:bocode:s457072<\/ext-link>"},{"key":"ref32","article-title":"Stata Statistical Software: Release 15. College Station","year":"2017"},{"issue":"1","key":"ref33","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1037\/a0024338","article-title":"Effect size estimates: Current use, calculations, and interpretation","volume":"141","author":"CO Fritz","year":"2012","journal-title":"J Exp Psychol Gen"},{"issue":"4","key":"ref34","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1111\/ppe.12378","article-title":"Antidepressant Use in Pregnancy and the Risk of Attention Deficit with or without Hyperactivity Disorder in Children","volume":"31","author":"T Boukhris","year":"2017","journal-title":"Paediatr Perinat Epidemiol"},{"issue":"14","key":"ref35","doi-asserted-by":"crossref","first-page":"726","DOI":"10.1056\/NEJM197504032921405","article-title":"Antenatal Exposure to Meprobamate and Chlordiazepoxide in Relation to Malformations, Mental Development, and Childhood Mortality","volume":"292","author":"SC Hartz","year":"1975","journal-title":"N Engl J Med"},{"issue":"4","key":"ref36","doi-asserted-by":"crossref","first-page":"330","DOI":"10.1016\/S0009-9236(02)17634-X","article-title":"Pharmacokinetics of fluoxetine and norfluoxetine in pregnancy and lactation","volume":"73","author":"T Heikkinen","year":"2003","journal-title":"Clin Pharmacol Ther"},{"issue":"9","key":"ref37","doi-asserted-by":"crossref","first-page":"e003507","DOI":"10.1136\/bmjopen-2013-003507","article-title":"In utero exposure to antidepressant drugs and risk of attention deficit hyperactivity disorder: a nationwide Danish cohort study","volume":"3","author":"K Laugesen","year":"2013","journal-title":"BMJ Open"},{"key":"ref38","doi-asserted-by":"crossref","DOI":"10.3389\/fpsyt.2012.00011","article-title":"Affect Expression and Self-Regulation Capacities of Infants Exposed in utero to Psychotropics","volume":"3","author":"PN Reebye","year":"2012","journal-title":"Front Psychiatry"},{"issue":"2","key":"ref39","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1002\/tera.1420350207","article-title":"Aspirin and acetaminophen use by pregnant women and subsequent child IQ and attention decrements","volume":"35","author":"AP Streissguth","year":"1987","journal-title":"Teratology"},{"issue":"3","key":"ref40","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1111\/j.1469-7610.1993.tb00993.x","article-title":"Mental development in late infancy after prenatal exposure to benzodiazepines\u2014a prospective study","volume":"34","author":"G Viggedal","year":"1993","journal-title":"J Child Psychol Psychiatry"},{"issue":"16","key":"ref41","doi-asserted-by":"crossref","first-page":"2787","DOI":"10.1017\/S0033291717001301","article-title":"Autism risk following antidepressant medication during pregnancy","volume":"47","author":"A Viktorin","year":"2017","journal-title":"Psychol Med"},{"key":"ref42","doi-asserted-by":"crossref","first-page":"dyw192","DOI":"10.1093\/ije\/dyw192","article-title":"Neurodevelopmental problems at 18 months among children exposed to paracetamol in utero: a propensity score matched cohort study","author":"R Vlenterie","year":"2016","journal-title":"Int J Epidemiol"},{"issue":"11","key":"ref43","first-page":"1054","article-title":"Infant neurodevelopment following in utero exposure to antidepressant medication","volume":"102","author":"M-P Austin","year":"2013","journal-title":"Acta Paediatr Oslo Nor"},{"issue":"4","key":"ref44","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1055\/s-0032-1324697","article-title":"In utero antidepressant exposure and neurodevelopment in preterm infants","volume":"30","author":"B Batton","year":"2013","journal-title":"Am J Perinatol"},{"issue":"2","key":"ref45","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1001\/jamapediatrics.2015.3356","article-title":"Antidepressant Use During Pregnancy and the Risk of Autism Spectrum Disorder in Children","volume":"170","author":"T Boukhris","year":"2016","journal-title":"JAMA Pediatr"},{"issue":"4","key":"ref46","doi-asserted-by":"crossref","first-page":"1397","DOI":"10.1093\/ije\/dyv030","article-title":"Behavioural effects of fetal antidepressant exposure in a Norwegian cohort of discordant siblings","volume":"44","author":"RE Brandlistuen","year":"2015","journal-title":"Int J Epidemiol"},{"issue":"11","key":"ref47","doi-asserted-by":"crossref","first-page":"1163","DOI":"10.1001\/jamapsychiatry.2016.2594","article-title":"Association of Selective Serotonin Reuptake Inhibitor Exposure During Pregnancy With Speech, Scholastic, and Motor Disorders in Offspring","volume":"73","author":"AS Brown","year":"2016","journal-title":"JAMA Psychiatry"},{"issue":"15","key":"ref48","doi-asserted-by":"crossref","first-page":"1544","DOI":"10.1001\/jama.2017.3415","article-title":"Association Between Serotonergic Antidepressant Use During Pregnancy and Autism Spectrum Disorder in Children","volume":"317","author":"HK Brown","year":"2017","journal-title":"JAMA"},{"issue":"4","key":"ref49","doi-asserted-by":"crossref","first-page":"402","DOI":"10.1067\/mpd.2003.139","article-title":"Follow-up of children of depressed mothers exposed or not exposed to antidepressant drugs during pregnancy","volume":"142","author":"RC Casper","year":"2003","journal-title":"J Pediatr"},{"issue":"101562664","key":"ref50","doi-asserted-by":"crossref","first-page":"e708","DOI":"10.1038\/tp.2015.190","article-title":"Absence of evidence for increase in risk for autism or attention-deficit hyperactivity disorder following antidepressant exposure during pregnancy: a replication study","volume":"6","author":"VM Castro","year":"2016","journal-title":"Transl Psychiatry"},{"issue":"6","key":"ref51","doi-asserted-by":"crossref","first-page":"727","DOI":"10.1038\/mp.2014.90","article-title":"Prenatal antidepressant exposure is associated with risk for attention-deficit hyperactivity disorder but not autism spectrum disorder in a large health system","volume":"20","author":"CC Clements","year":"2015","journal-title":"Mol Psychiatry"},{"issue":"11","key":"ref52","doi-asserted-by":"crossref","first-page":"1104","DOI":"10.1001\/archgenpsychiatry.2011.73","article-title":"Antidepressant use during pregnancy and childhood autism spectrum disorders","volume":"68","author":"LA Croen","year":"2011","journal-title":"Arch Gen Psychiatry"},{"issue":"5","key":"ref53","first-page":"e64654","article-title":"Early Neurological Outcome of Young Infants Exposed to Selective Serotonin Reuptake Inhibitors during Pregnancy: Results from the Observational SMOK Study. Scott JG, editor","volume":"8","author":"NKS de Vries","year":"2013","journal-title":"May 28"},{"issue":"2","key":"ref54","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1192\/bjp.bp.113.127746","article-title":"Prenatal exposure to selective serotonin reuptake inhibitors and social responsiveness symptoms of autism: population-based study of young children","volume":"205","author":"H El Marroun","year":"2014","journal-title":"Br J Psychiatry J Ment Sci"},{"issue":"3","key":"ref55","doi-asserted-by":"crossref","first-page":"346","DOI":"10.1177\/0269881116665335","article-title":"Prenatal exposure to selective serotonin reuptake inhibitors and non-verbal cognitive functioning in childhood","volume":"31","author":"H El Marroun","year":"2017","journal-title":"J Psychopharmacol Oxf Engl"},{"issue":"8","key":"ref56","doi-asserted-by":"crossref","first-page":"641","DOI":"10.1097\/DBP.0b013e3181e5ac93","article-title":"Use of antidepressants during pregnancy and risk of attention-deficit\/hyperactivity disorder in the offspring","volume":"31","author":"R Figueroa","year":"2010","journal-title":"J Dev Behav Pediatr JDBP"},{"issue":"5","key":"ref57","doi-asserted-by":"crossref","first-page":"393","DOI":"10.3109\/00048674.2010.549995","article-title":"Developmental outcomes of children exposed to antidepressants in pregnancy","volume":"45","author":"M Galbally","year":"2011","journal-title":"Aust N Z J Psychiatry"},{"issue":"7","key":"ref58","doi-asserted-by":"crossref","first-page":"642","DOI":"10.1177\/0004867415569800","article-title":"Child developmental outcomes in preschool children following antidepressant exposure in pregnancy","volume":"49","author":"M Galbally","year":"2015","journal-title":"Aust N Z J Psychiatry"},{"issue":"10","key":"ref59","doi-asserted-by":"crossref","first-page":"2558","DOI":"10.1007\/s10803-014-2128-4","article-title":"In utero exposure to selective serotonin reuptake inhibitors and risk for autism spectrum disorder","volume":"44","author":"NB Gidaya","year":"2014","journal-title":"J Autism Dev Disord"},{"issue":"12","key":"ref60","doi-asserted-by":"crossref","first-page":"1919","DOI":"10.1111\/1471-0528.13611","article-title":"Prenatal antidepressant exposure and child behavioural outcomes at 7 years of age: a study within the Danish National Birth Cohort","volume":"123","author":"LE Grzeskowiak","year":"2016","journal-title":"BJOG Int J Obstet Gynaecol"},{"issue":"3","key":"ref61","doi-asserted-by":"crossref","first-page":"773","DOI":"10.1017\/S0954579418000639","article-title":"Major depressive disorder during pregnancy: Psychiatric medications have minimal effects on the fetus and infant yet development is compromised","volume":"30","author":"HC Gustafsson","year":"2018","journal-title":"Dev Psychopathol"},{"issue":"12","key":"ref62","doi-asserted-by":"crossref","first-page":"1908","DOI":"10.1111\/1471-0528.13582","article-title":"Motor development in children prenatally exposed to selective serotonin reuptake inhibitors: a large population-based pregnancy cohort study","volume":"123","author":"M Handal","year":"2016","journal-title":"BJOG Int J Obstet Gynaecol"},{"issue":"4","key":"ref63","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1097\/JCP.0000000000000519","article-title":"Prenatal Exposure to Folic Acid and Antidepressants and Language Development: A Population-Based Cohort Study","volume":"36","author":"M Handal","year":"2016","journal-title":"J Clin Psychopharmacol"},{"issue":"8","key":"ref64","doi-asserted-by":"crossref","first-page":"519","DOI":"10.1016\/j.earlhumdev.2012.12.012","article-title":"Infant developmental outcomes following prenatal exposure to antidepressants, and maternal depressed mood and positive affect","volume":"89","author":"GE Hanley","year":"2013","journal-title":"Early Hum Dev"},{"issue":"2","key":"ref65","doi-asserted-by":"crossref","first-page":"174","DOI":"10.1038\/pr.2015.77","article-title":"Prenatal exposure to serotonin reuptake inhibitor antidepressants and childhood behavior","volume":"78","author":"GE Hanley","year":"2015","journal-title":"Pediatr Res"},{"issue":"5","key":"ref66","doi-asserted-by":"crossref","first-page":"e1241","DOI":"10.1542\/peds.2013-3406","article-title":"Prenatal SSRI use and offspring with autism spectrum disorder or developmental delay","volume":"133","author":"RA Harrington","year":"2014","journal-title":"Pediatrics"},{"issue":"2","key":"ref67","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1067\/mcp.2002.126181","article-title":"Citalopram in pregnancy and lactation","volume":"72","author":"T Heikkinen","year":"2002","journal-title":"Clin Pharmacol Ther"},{"issue":"8","key":"ref68","doi-asserted-by":"crossref","first-page":"1523","DOI":"10.1007\/s00213-016-4248-3","article-title":"Behavior and inhibitory control in children with prenatal exposure to antidepressants and medically untreated depression","volume":"233","author":"TK Hermansen","year":"2016","journal-title":"Psychopharmacology (Berl)"},{"issue":"5","key":"ref69","doi-asserted-by":"crossref","first-page":"476","DOI":"10.1111\/fcp.12209","article-title":"Psychomotor developmental effects of prenatal exposure to psychotropic drugs: a study in EFEMERIS database","volume":"30","author":"C Hurault-Delarue","year":"2016","journal-title":"Fundam Clin Pharmacol"},{"key":"ref70","article-title":"Impact of Prenatal Selective Serotonin Reuptake Inhibitor Antidepressant Exposure and Maternal Mood on Physical Activity, Dietary Intake, and Markers of Adiposity at Age 6 Years","author":"SM Hutchison","year":"2019","journal-title":"J Dev Behav Pediatr JDBP"},{"issue":"25","key":"ref71","doi-asserted-by":"crossref","first-page":"2406","DOI":"10.1056\/NEJMoa1301449","article-title":"Use of selective serotonin reuptake inhibitors during pregnancy and risk of autism","volume":"369","author":"A Hviid","year":"2013","journal-title":"N Engl J Med"},{"issue":"12","key":"ref72","doi-asserted-by":"crossref","first-page":"1217","DOI":"10.1001\/jamapsychiatry.2018.2728","article-title":"Association of Autism Spectrum Disorder With Prenatal Exposure to Medication Affecting Neurotransmitter Systems","volume":"75","author":"M Janecka","year":"2018","journal-title":"Jama Psychiatry"},{"issue":"8","key":"ref73","doi-asserted-by":"crossref","first-page":"787","DOI":"10.1001\/archgenpsychiatry.2012.160","article-title":"Prenatal antipsychotic exposure and neuromotor performance during infancy","volume":"69","author":"KC Johnson","year":"2012","journal-title":"Arch Gen Psychiatry"},{"issue":"2","key":"ref74","doi-asserted-by":"crossref","first-page":"e176","DOI":"10.4088\/JCP.14m09348","article-title":"Preschool outcomes following prenatal serotonin reuptake inhibitor exposure: differences in language and behavior, but not cognitive function","volume":"77","author":"KC Johnson","year":"2016","journal-title":"J Clin Psychiatry"},{"key":"ref75","doi-asserted-by":"crossref","first-page":"j3668","DOI":"10.1136\/bmj.j3668","article-title":"Antidepressant use during pregnancy and psychiatric disorders in offspring: Danish nationwide register based cohort study","volume":"358","author":"X Liu","year":"2017","journal-title":"Bmj-Br Med J"},{"issue":"3","key":"ref76","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1016\/j.jaac.2017.12.010","article-title":"Effect of Time-Dependent Selective Serotonin Reuptake Inhibitor Antidepressants During Pregnancy on Behavioral, Emotional, and Social Development in Preschool-Aged Children","volume":"57","author":"A Lupattelli","year":"2018","journal-title":"J Am Acad Child Adolesc Psychiatry"},{"issue":"5","key":"ref77","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1016\/j.jaac.2016.02.013","article-title":"Gestational Exposure to Selective Serotonin Reuptake Inhibitors and Offspring Psychiatric Disorders: A National Register-Based Study","volume":"55","author":"H Malm","year":"2016","journal-title":"J Am Acad Child Adolesc Psychiatry"},{"issue":"8900488, bmj, 101090866","key":"ref78","first-page":"j2350","article-title":"Prenatal antidepressant use and risk of attention-deficit\/hyperactivity disorder in offspring: population based cohort study","volume":"357","author":"KKC Man","year":"2017","journal-title":"BMJ"},{"issue":"3","key":"ref79","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1016\/S0892-0362(02)00198-8","article-title":"Interaction of maternal smoking and other in-pregnancy exposures: analytic considerations","volume":"24","author":"SN Mattson","year":"2002","journal-title":"Neurotoxicol Teratol"},{"issue":"6","key":"ref80","doi-asserted-by":"crossref","first-page":"1026","DOI":"10.1176\/ajp.2006.163.6.1026","article-title":"Internalizing behaviors in 4-year-old children exposed in utero to psychotropic medications","volume":"163","author":"S Misri","year":"2006","journal-title":"Am J Psychiatry"},{"issue":"8","key":"ref81","doi-asserted-by":"crossref","first-page":"769","DOI":"10.1023\/A:1025306304635","article-title":"Psychomotor development in children exposed in utero to benzodiazepines, antidepressants, neuroleptics, and anti-epileptics","volume":"18","author":"JT Mortensen","year":"2003","journal-title":"Eur J Epidemiol"},{"key":"ref82","doi-asserted-by":"crossref","first-page":"252","DOI":"10.1016\/j.jad.2015.08.055","article-title":"Infant outcomes following treatment of antenatal depression: Findings from a pilot randomized controlled trial","volume":"188","author":"E Netsi","year":"2015","journal-title":"J Affect Disord"},{"issue":"4","key":"ref83","doi-asserted-by":"crossref","first-page":"258","DOI":"10.1056\/NEJM199701233360404","article-title":"Neurodevelopment of Children Exposed in Utero to Antidepressant Drugs","volume":"336","author":"I Nulman","year":"1997","journal-title":"N Engl J Med"},{"issue":"11","key":"ref84","doi-asserted-by":"crossref","first-page":"1889","DOI":"10.1176\/appi.ajp.159.11.1889","article-title":"Child development following exposure to tricyclic antidepressants or fluoxetine throughout fetal life: a prospective, controlled study","volume":"159","author":"I Nulman","year":"2002","journal-title":"Am J Psychiatry"},{"issue":"11","key":"ref85","doi-asserted-by":"crossref","first-page":"1165","DOI":"10.1176\/appi.ajp.2012.11111721","article-title":"Neurodevelopment of children following prenatal exposure to venlafaxine, selective serotonin reuptake inhibitors, or untreated maternal depression","volume":"169","author":"I Nulman","year":"2012","journal-title":"Am J Psychiatry"},{"issue":"7","key":"ref86","doi-asserted-by":"crossref","first-page":"e842","DOI":"10.4088\/JCP.14m09240","article-title":"Neurodevelopment of children prenatally exposed to selective reuptake inhibitor antidepressants: Toronto sibling study","volume":"76","author":"I Nulman","year":"2015","journal-title":"J Clin Psychiatry"},{"issue":"2","key":"ref87","doi-asserted-by":"crossref","first-page":"230","DOI":"10.4088\/JCP.v65n0214","article-title":"Pharmacologic factors associated with transient neonatal symptoms following prenatal psychotropic medication exposure","volume":"65","author":"TF Oberlander","year":"2004","journal-title":"J Clin Psychiatry"},{"issue":"1","key":"ref88","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1001\/archpedi.161.1.22","article-title":"Externalizing and attentional behaviors in children of depressed mothers treated with a selective serotonin reuptake inhibitor antidepressant during pregnancy","volume":"161","author":"TF Oberlander","year":"2007","journal-title":"Arch Pediatr Adolesc Med"},{"issue":"5","key":"ref89","doi-asserted-by":"crossref","first-page":"444","DOI":"10.1001\/archpediatrics.2010.51","article-title":"Prenatal effects of selective serotonin reuptake inhibitor antidepressants, serotonin transporter promoter genotype (SLC6A4), and maternal mood on child behavior at 3 years of age","volume":"164","author":"TF Oberlander","year":"2010","journal-title":"Arch Pediatr Adolesc Med"},{"issue":"2","key":"ref90","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1111\/acps.12032","article-title":"Prenatal antidepressant exposure and behavioral problems in early childhood\u2014a cohort study","volume":"127","author":"LH Pedersen","year":"2013","journal-title":"Acta Psychiatr Scand"},{"issue":"8900488, bmj, 101090866","key":"ref91","doi-asserted-by":"crossref","first-page":"j2811","DOI":"10.1136\/bmj.j2811","article-title":"Antidepressants during pregnancy and autism in offspring: population based cohort study","volume":"358","author":"D Rai","year":"2017","journal-title":"BMJ"},{"issue":"4","key":"ref92","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1002\/imhj.10025","article-title":"Affect expression in prenatally psychotropic exposed and nonexposed mother-infant dyads","volume":"23","author":"PN Reebye","year":"2002","journal-title":"Infant Ment Health J"},{"issue":"10","key":"ref93","doi-asserted-by":"crossref","first-page":"1088","DOI":"10.4088\/JCP.13m08902","article-title":"Impact of prenatal exposure to serotonin reuptake inhibitors or maternal major depressive disorder on infant developmental outcomes","volume":"75","author":"AK Santucci","year":"2014","journal-title":"J Clin Psychiatry"},{"issue":"2","key":"ref94","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1007\/s10802-016-0161-9","article-title":"Maternal Prenatal Psychological Distress and Preschool Cognitive Functioning: the Protective Role of Positive Parental Engagement","volume":"45","author":"JC Schechter","year":"2017","journal-title":"J Abnorm Child Psychol"},{"issue":"12","key":"ref95","doi-asserted-by":"crossref","first-page":"2055","DOI":"10.1176\/appi.ajp.159.12.2055","article-title":"Outcomes of prenatal antidepressant exposure","volume":"159","author":"GE Simon","year":"2002","journal-title":"Am J Psychiatry"},{"issue":"13","key":"ref96","doi-asserted-by":"crossref","first-page":"1621","DOI":"10.1111\/1471-0528.12821","article-title":"Prenatal exposure to antidepressants and language competence at age three: results from a large population-based pregnancy cohort in Norway","volume":"121","author":"S Skurtveit","year":"2014","journal-title":"BJOG Int J Obstet Gynaecol"},{"issue":"101531700","key":"ref97","doi-asserted-by":"crossref","first-page":"449","DOI":"10.2147\/CLEP.S53009","article-title":"Antidepressant exposure in pregnancy and risk of autism spectrum disorders","volume":"5","author":"MJ Sorensen","year":"2013","journal-title":"Clin Epidemiol"},{"issue":"15","key":"ref98","doi-asserted-by":"crossref","first-page":"1553","DOI":"10.1001\/jama.2017.3413","article-title":"Associations of Maternal Antidepressant Use During the First Trimester of Pregnancy With Preterm Birth, Small for Gestational Age, Autism Spectrum Disorder, and Attention-Deficit\/Hyperactivity Disorder in Offspring","volume":"317","author":"AC Sujan","year":"2017","journal-title":"Jama-J Am Med Assoc"},{"issue":"7","key":"ref99","doi-asserted-by":"crossref","first-page":"1002","DOI":"10.4088\/JCP.10m06135","article-title":"A prospective, naturalistic, blinded study of early neurobehavioral outcomes for infants following prenatal antidepressant exposure","volume":"72","author":"R Suri","year":"2011","journal-title":"J Clin Psychiatry"},{"issue":"10","key":"ref100","doi-asserted-by":"crossref","first-page":"1031","DOI":"10.1001\/jamapsychiatry.2017.1727","article-title":"Association of Antidepressant Medication Use During Pregnancy With Intellectual Disability in Offspring","volume":"74","author":"A Viktorin","year":"2017","journal-title":"JAMA Psychiatry"},{"issue":"4","key":"ref101","doi-asserted-by":"crossref","first-page":"485","DOI":"10.1016\/j.infbeh.2013.04.001","article-title":"The impact of prenatal serotonin reuptake inhibitor (SRI) antidepressant exposure and maternal mood on mother-infant interactions at 3 months of age","volume":"36","author":"WM Weikum","year":"2013","journal-title":"Infant Behav Dev"},{"issue":"101477935","key":"ref102","first-page":"180","article-title":"Prenatal serotonin reuptake inhibitor (SRI) antidepressant exposure and serotonin transporter promoter genotype (SLC6A4) influence executive functions at 6 years of age","volume":"7","author":"WM Weikum","year":"2013","journal-title":"Front Cell Neurosci"},{"issue":"2","key":"ref103","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1111\/acps.12754","article-title":"Risk of impaired cognition after prenatal exposure to psychotropic drugs","volume":"136","author":"MA Wibroe","year":"2017","journal-title":"Acta Psychiatr Scand"},{"issue":"7","key":"ref104","doi-asserted-by":"crossref","first-page":"e0181042","DOI":"10.1371\/journal.pone.0181042","article-title":"Association of prenatal exposure to benzodiazepines and child internalizing problems: A sibling-controlled cohort study","volume":"12","author":"RE Brandlistuen","year":"2017","journal-title":"PloS One"},{"issue":"1\u20132","key":"ref105","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1177\/0748233708089017","article-title":"An evaluation of data for 10 children born to mothers who attempted suicide by taking large doses of alprazolam during pregnancy","volume":"24","author":"J Gidai","year":"2008","journal-title":"Toxicol Ind Health"},{"issue":"1\u20132","key":"ref106","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1177\/0748233708089016","article-title":"A study of the effects of large doses of medazepam used for self-poisoning in 10 pregnant women on fetal development","volume":"24","author":"J Gidai","year":"2008","journal-title":"Toxicol Ind Health"},{"issue":"1\u20132","key":"ref107","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1177\/0748233708089018","article-title":"A study of the teratogenic and fetotoxic effects of large doses of chlordiazepoxide used for self-poisoning by 35 pregnant women","volume":"24","author":"J Gidai","year":"2008","journal-title":"Toxicol Ind Health"},{"issue":"2","key":"ref108","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1055\/s-2008-1071314","article-title":"Neurodevelopment in late infancy after prenatal exposure to benzodiazepines\u2014a prospective study","volume":"23","author":"L Laegreid","year":"1992","journal-title":"Neuropediatrics"},{"issue":"4","key":"ref109","doi-asserted-by":"crossref","first-page":"e191435","DOI":"10.1001\/jamanetworkopen.2019.1435","article-title":"Association of Maternal Use of Benzodiazepines and Z-Hypnotics During Pregnancy With Motor and Communication Skills and Attention-Deficit\/Hyperactivity Disorder Symptoms in Preschoolers","volume":"2","author":"A Lupattelli","year":"2019","journal-title":"JAMA Netw Open"},{"issue":"3","key":"ref110","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1007\/s00228-014-1797-4","article-title":"Prenatal exposure to anxiolytics and hypnotics and language competence at 3 years of age","volume":"71","author":"I Odsbu","year":"2015","journal-title":"Eur J Clin Pharmacol"},{"key":"ref111","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1016\/j.ntt.2017.02.005","article-title":"Prenatal exposure to anxiolytic and hypnotic medication in relation to behavioral problems in childhood: A population-based cohort study","volume":"61","author":"MR Radojcic","year":"2017","journal-title":"Neurotoxicol Teratol"},{"issue":"1\u20132","key":"ref112","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1177\/0748233708089015","article-title":"A study of teratogenic and fetotoxic effects of large doses of meprobamate used for a suicide attempt by 42 pregnant women","volume":"24","author":"G Timmermann","year":"2008","journal-title":"Toxicol Ind Health"},{"issue":"4","key":"ref113","doi-asserted-by":"crossref","first-page":"577","DOI":"10.1007\/s00213-013-3060-6","article-title":"Effects of prenatal exposure to atypical antipsychotics on postnatal development and growth of infants: a case-controlled, prospective study","volume":"228","author":"M Peng","year":"2013","journal-title":"Psychopharmacology (Berl)"},{"issue":"3","key":"ref114","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1002\/hup.470040306","article-title":"Effects of prenatal neuroleptic drug exposure on motor performance in children","volume":"4","author":"JE Platt","year":"1989","journal-title":"Hum Psychopharmacol Clin Exp"},{"issue":"1\u20132","key":"ref115","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1177\/0748233708089014","article-title":"A study of the effects of large doses of glutethimide that were used for self-poisoning during pregnancy on human fetuses","volume":"24","author":"D Petik","year":"2008","journal-title":"Toxicol Ind Health"},{"issue":"1\u20132","key":"ref116","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1177\/0748233708093314","article-title":"A study of the teratogenic and fetotoxic effects of large doses of amobarbital used for a suicide attempt by 14 pregnant women","volume":"24","author":"D Petik","year":"2008","journal-title":"Toxicol Ind Health"},{"issue":"1\u20132","key":"ref117","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1177\/0748233708089004","article-title":"A study of the teratogenic and fetotoxic effects of large doses of barbital, hexobarbital and butobarbital used for suicide attempts by pregnant women","volume":"24","author":"G Timmermann","year":"2008","journal-title":"Toxicol Ind Health"},{"issue":"6","key":"ref118","first-page":"1987","article-title":"Acetaminophen use in pregnancy and neurodevelopment: attention function and autism spectrum symptoms","volume":"45","author":"CB Avella-Garcia","year":"2016","journal-title":"Int J Epidemiol"},{"key":"ref119","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1016\/j.eurpsy.2017.10.007","article-title":"Prenatal exposure to acetaminophen and children\u2019s language development at 30 months","volume":"51","author":"C-G Bornehag","year":"2018","journal-title":"Eur Psychiatry"},{"issue":"6","key":"ref120","doi-asserted-by":"crossref","first-page":"1702","DOI":"10.1093\/ije\/dyt183","article-title":"Prenatal paracetamol exposure and child neurodevelopment: a sibling-controlled cohort study","volume":"42","author":"RE Brandlistuen","year":"2013","journal-title":"Int J Epidemiol"},{"issue":"1","key":"ref121","doi-asserted-by":"crossref","first-page":"138","DOI":"10.1093\/toxsci\/kfy222","article-title":"Association Between Meconium Acetaminophen and Childhood Neurocognitive Development in GESTE, a Canadian Cohort Study","volume":"167","author":"HE Laue","year":"2019","journal-title":"Toxicol Sci"},{"issue":"4","key":"ref122","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1001\/jamapediatrics.2013.4914","article-title":"Acetaminophen use during pregnancy, behavioral problems, and hyperkinetic disorders","volume":"168","author":"Z Liew","year":"2014","journal-title":"JAMA Pediatr"},{"issue":"9","key":"ref123","doi-asserted-by":"crossref","first-page":"951","DOI":"10.1002\/aur.1591","article-title":"Maternal use of acetaminophen during pregnancy and risk of autism spectrum disorders in childhood: A Danish national birth cohort study: Acetaminophen and Autism Spectrum Disorders","volume":"9","author":"Z Liew","year":"2016","journal-title":"Autism Res"},{"issue":"6","key":"ref124","first-page":"2009","article-title":"Paracetamol use during pregnancy and attention and executive function in offspring at age 5 years","volume":"45","author":"Z Liew","year":"2016","journal-title":"Int J Epidemiol"},{"issue":"6","key":"ref125","doi-asserted-by":"crossref","first-page":"912","DOI":"10.1097\/EDE.0000000000000540","article-title":"Prenatal Use of Acetaminophen and Child IQ: A Danish Cohort Study","volume":"27","author":"Z Liew","year":"2016","journal-title":"Epidemiology"},{"issue":"4","key":"ref126","doi-asserted-by":"crossref","first-page":"768","DOI":"10.1093\/aje\/kwy288","article-title":"Use of Negative Control Exposure Analysis to Evaluate Confounding: An Example of Acetaminophen Exposure and Attention-Deficit\/Hyperactivity Disorder in Nurses\u2019 Health Study II","volume":"188","author":"Z Liew","year":"2019","journal-title":"Am J Epidemiol"},{"key":"ref127","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1016\/j.jpsychires.2018.02.020","article-title":"Pregnancy risk factors in relation to oppositional-defiant and conduct disorder symptoms in the Avon Longitudinal Study of Parents and Children","volume":"101","author":"IH Ruisch","year":"2018","journal-title":"J Psychiatr Res"},{"issue":"6","key":"ref128","doi-asserted-by":"crossref","first-page":"625","DOI":"10.1002\/pds.4170","article-title":"Language competence and communication skills in 3-year-old children after prenatal exposure to analgesic opioids","volume":"26","author":"E Skovlund","year":"2017","journal-title":"Pharmacoepidemiol Drug Saf"},{"issue":"10","key":"ref129","doi-asserted-by":"crossref","first-page":"964","DOI":"10.1001\/jamapediatrics.2016.1775","article-title":"Association of Acetaminophen Use During Pregnancy With Behavioral Problems in Childhood: Evidence Against Confounding","volume":"170","author":"E Stergiakouli","year":"2016","journal-title":"JAMA Pediatr"},{"issue":"9","key":"ref130","doi-asserted-by":"crossref","first-page":"e108210","DOI":"10.1371\/journal.pone.0108210","article-title":"Associations between acetaminophen use during pregnancy and ADHD symptoms measured at ages 7 and 11 years","volume":"9","author":"JMD Thompson","year":"2014","journal-title":"PloS One"},{"key":"ref131","doi-asserted-by":"crossref","first-page":"368","DOI":"10.1186\/s12888-018-1942-1","article-title":"Is intrauterine exposure to acetaminophen associated with emotional and hyperactivity problems during childhood? Findings from the 2004 Pelotas birth cohort","volume":"18","author":"L Tovo-Rodrigues","year":"2018","journal-title":"Bmc Psychiatry"},{"issue":"5","key":"ref132","doi-asserted-by":"crossref","first-page":"e20163840","DOI":"10.1542\/peds.2016-3840","article-title":"Prenatal Exposure to Acetaminophen and Risk of ADHD","volume":"140","author":"E Ystrom","year":"2017","journal-title":"Pediatrics"},{"issue":"4","key":"ref133","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1515\/jpme.1996.24.4.405","article-title":"Neurodevelopmental outcome of infants exposed to indomethacin antenatally","volume":"24","author":"S al-Alaiyan","year":"1996","journal-title":"J Perinat Med"},{"issue":"1","key":"ref134","doi-asserted-by":"crossref","first-page":"41.e1","DOI":"10.1016\/j.ajog.2007.12.037","article-title":"Neurodevelopmental outcome of premature infants after exposure to antenatal indomethacin","volume":"199","author":"SB Amin","year":"2008","journal-title":"Am J Obstet Gynecol"},{"issue":"4","key":"ref135","doi-asserted-by":"crossref","first-page":"452","DOI":"10.1002\/pds.4625","article-title":"Prenatal exposure to non-steroidal anti-inflammatory drugs (NSAIDs) and neurodevelopmental outcomes in children","volume":"28","author":"M Markovic","year":"2019","journal-title":"Pharmacoepidemiol Drug Saf"},{"issue":"4","key":"ref136","doi-asserted-by":"crossref","first-page":"174","DOI":"10.1055\/s-2007-973782","article-title":"Growth and development until 18 months of children exposed to tocolytics indomethacin or nylidrin","volume":"27","author":"T Salokorpi","year":"1996","journal-title":"Neuropediatrics"},{"issue":"3","key":"ref137","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1037\/0012-1649.26.3.339","article-title":"Prenatal exposure to alcohol, caffeine, tobacco, and aspirin: Effects on fine and gross motor performance in 4-year-old children","volume":"26","author":"HM Barr","year":"1990","journal-title":"Dev Psychol"},{"issue":"3","key":"ref138","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1002\/tera.1420370310","article-title":"Aspirin exposure during the first 20 weeks of gestation and IQ at four years of age","volume":"37","author":"MA Klebanoff","year":"1988","journal-title":"Teratology"},{"issue":"3","key":"ref139","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1111\/ppe.12461","article-title":"Prenatal triptan exposure and neurodevelopmental outcomes in 5-year-old children: Follow-up from the Norwegian Mother and Child Cohort Study","volume":"32","author":"G-ME Harris","year":"2018","journal-title":"Paediatr Perinat Epidemiol"},{"issue":"9","key":"ref140","doi-asserted-by":"crossref","first-page":"e011971","DOI":"10.1136\/bmjopen-2016-011971","article-title":"Longitudinal changes in neurodevelopmental outcomes between 18 and 36 months in children with prenatal triptan exposure: findings from the Norwegian Mother and Child Cohort Study","volume":"6","author":"ME Wood","year":"2016","journal-title":"BMJ Open"},{"issue":"2","key":"ref141","doi-asserted-by":"crossref","first-page":"190","DOI":"10.1111\/ppe.12253","article-title":"Prenatal Triptan Exposure and Internalising and Externalising Behaviour Problems in 3-Year-Old Children: Results from the Norwegian Mother and Child Cohort Study: Prenatal triptan exposure and externalising symptoms","volume":"30","author":"ME Wood","year":"2016","journal-title":"Paediatr Perinat Epidemiol"},{"issue":"5","key":"ref142","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1002\/pds.3902","article-title":"Prenatal triptan exposure and parent-reported early childhood neurodevelopmental outcomes: an application of propensity score calibration to adjust for unmeasured confounding by migraine severity","volume":"25","author":"ME Wood","year":"2016","journal-title":"Pharmacoepidemiol Drug Saf"},{"issue":"1","key":"ref143","doi-asserted-by":"crossref","first-page":"376","DOI":"10.1007\/s10803-018-3721-8","article-title":"Brief Report: Maternal Opioid Prescription from Preconception Through Pregnancy and the Odds of Autism Spectrum Disorder and Autism Features in Children","volume":"49","author":"E Rubenstein","year":"2019","journal-title":"J Autism Dev Disord"},{"issue":"5","key":"ref144","doi-asserted-by":"crossref","first-page":"1007","DOI":"10.1542\/peds.2011-2654","article-title":"Subcommittee on Attention-Deficit\/Hyperactivity Disorder, Steering Committee on Quality Improvement and Management. ADHD: Clinical Practice Guideline for the Diagnosis, Evaluation, and Treatment of Attention-Deficit\/Hyperactivity Disorder in Children and Adolescents","volume":"128","year":"2011","journal-title":"PEDIATRICS"},{"issue":"3","key":"ref145","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1016\/j.yebeh.2007.08.015","article-title":"Antiepileptic drug exposure and major congenital malformations: The role of pregnancy registries","volume":"11","author":"T Tomson","year":"2007","journal-title":"Epilepsy Behav"},{"issue":"2","key":"ref146","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1002\/(SICI)1096-9861(19960624)370:2<247::AID-CNE8>3.0.CO;2-2","article-title":"Embryological origin for autism: developmental anomalies of the cranial nerve motor nuclei","volume":"370","author":"PM Rodier","year":"1996","journal-title":"J Comp Neurol"},{"issue":"1","key":"ref147","doi-asserted-by":"crossref","first-page":"294","DOI":"10.1016\/j.psychres.2013.03.025","article-title":"Correction of distortions in distressed mothers\u2019 ratings of their preschool children\u2019s psychopathology","volume":"210","author":"JM M\u00fcller","year":"2013","journal-title":"Psychiatry Res"},{"issue":"4","key":"ref148","doi-asserted-by":"crossref","first-page":"186","DOI":"10.1007\/s001270170062","article-title":"Bias influencing maternal reports of child behaviour and emotional state","volume":"36","author":"JM Najman","year":"2001","journal-title":"Soc Psychiatry Psychiatr Epidemiol"},{"issue":"4","key":"ref149","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1007\/s00787-009-0062-3","article-title":"Maternal depressive symptoms, and not anxiety symptoms, are associated with positive mother-child reporting discrepancies of internalizing problems in children: a report on the TRAILS study","volume":"19","author":"SLM van der Toorn","year":"2010","journal-title":"Eur Child Adolesc Psychiatry"},{"issue":"6","key":"ref150","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1023\/A:1022614800179","article-title":"The influence of distress on mothers\u2019 and fathers\u2019 reports of childhood emotional and behavioral problems","volume":"26","author":"MG Sawyer","year":"1998","journal-title":"J Abnorm Child Psychol"},{"issue":"2","key":"ref151","doi-asserted-by":"crossref","first-page":"434","DOI":"10.1093\/ije\/dyt261","article-title":"ADHD prevalence estimates across three decades: an updated systematic review and meta-regression analysis","volume":"43","author":"GV Polanczyk","year":"2014","journal-title":"Int J Epidemiol"},{"issue":"2","key":"ref152","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1037\/0033-2909.101.2.213","article-title":"Child\/adolescent behavioral and emotional problems: Implications of cross-informant correlations for situational specificity","volume":"101","author":"TM Achenbach","year":"1987","journal-title":"Psychol Bull"},{"issue":"8","key":"ref153","doi-asserted-by":"crossref","first-page":"551","DOI":"10.1017\/S0012162205001076","article-title":"Characteristics of fetal anticonvulsant syndrome associated autistic disorder","volume":"47","author":"A Rasalam","year":"2005","journal-title":"Dev Med Child Neurol"},{"key":"ref154","first-page":"135","article-title":"Informatic Morphogenetic Variants. In: Issue and reviews in teratology: 3","author":"L Pinsky","year":"1985"},{"issue":"mar17 10","key":"ref155","doi-asserted-by":"crossref","first-page":"h1035","DOI":"10.1136\/bmj.h1035","article-title":"Statins and congenital malformations: cohort study","volume":"350","author":"BT Bateman","year":"2015","journal-title":"BMJ"},{"issue":"1","key":"ref156","doi-asserted-by":"crossref","DOI":"10.1186\/s12916-017-0993-3","article-title":"Antidepressant use during pregnancy and risk of autism spectrum disorder and attention deficit hyperactivity disorder: systematic review of observational studies and methodological considerations","volume":"16","author":"DR Morales","year":"2018","journal-title":"BMC Med"},{"issue":"6","key":"ref157","doi-asserted-by":"crossref","first-page":"555","DOI":"10.1001\/jamapediatrics.2017.0124","article-title":"Risk for Autism Spectrum Disorders According to Period of Prenatal Antidepressant Exposure: A Systematic Review and Meta-analysis. [Review]","volume":"171","author":"A Mezzacappa","year":"2017","journal-title":"JAMA Pediatr"},{"issue":"be4, 8803591","key":"ref158","doi-asserted-by":"crossref","first-page":"170","DOI":"10.1016\/j.reprotox.2016.07.016","article-title":"Autism spectrum disorder and prenatal exposure to selective serotonin reuptake inhibitors: A systematic review and meta-analysis","volume":"65","author":"T Kobayashi","year":"2016","journal-title":"Reprod Toxicol Elmsford N"},{"issue":"5","key":"ref159","doi-asserted-by":"crossref","first-page":"543","DOI":"10.1080\/09297049.2014.942727","article-title":"Prenatal SSRI exposure: Effects on later child development","volume":"21","author":"TK Hermansen","year":"2015","journal-title":"Child Neuropsychol"},{"issue":"1","key":"ref160","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1146\/annurev.clinpsy.121208.131413","article-title":"Group-Based Trajectory Modeling in Clinical Research","volume":"6","author":"DS Nagin","year":"2010","journal-title":"Annu Rev Clin Psychol"},{"key":"ref161","first-page":"64","article-title":"Construct validity and external validity. In: Experimental and quasi-experimental designs for generalized causal inference","author":"WR Shadish","year":"2001"},{"issue":"9","key":"ref162","doi-asserted-by":"crossref","first-page":"1340","DOI":"10.1176\/ajp.151.9.1340","article-title":"The ICD-10 clinical field trial for mental and behavioral disorders: results in Canada and the United States","volume":"151","author":"DA Regier","year":"1994","journal-title":"Am J Psychiatry"},{"issue":"1","key":"ref163","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1080\/01942630802574908","article-title":"The Movement Assessment Battery for Children\u2014Second Edition (MABC-2): A Review and Critique","volume":"29","author":"T Brown","year":"2009","journal-title":"Phys Occup Ther Pediatr"},{"issue":"1","key":"ref164","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1093\/aje\/kwr045","article-title":"Placental abruption and perinatal mortality with preterm delivery as a mediator: disentangling direct and indirect effects","volume":"174","author":"CV Ananth","year":"2011","journal-title":"Am J Epidemiol"},{"issue":"3","key":"ref165","doi-asserted-by":"crossref","first-page":"280","DOI":"10.1016\/j.reprotox.2012.01.006","article-title":"Investigating outcomes associated with medication use during pregnancy: A review of methodological challenges and observational study designs","volume":"33","author":"LE Grzeskowiak","year":"2012","journal-title":"Reprod Toxicol"},{"key":"ref166","article-title":"Advances in Epidemiological Methods and Utilisation of Large Databases: A Methodological Review of Observational Studies on Central Nervous System Drug Use in Pregnancy and Central Nervous System Outcomes in Children","author":"Z Wang","year":"2018","journal-title":"Drug Saf"}],"container-title":["PLOS ONE"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/dx.plos.org\/10.1371\/journal.pone.0219778","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,5,9]],"date-time":"2020-05-09T07:27:47Z","timestamp":1589009267000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0219778"}},"subtitle":[],"editor":[{"given":"Andrea","family":"Martinuzzi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]}],"short-title":[],"issued":{"date-parts":[[2019,7,11]]},"references-count":166,"journal-issue":{"issue":"7","published-online":{"date-parts":[[2019,7,11]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pone.0219778","relation":{},"ISSN":["1932-6203"],"issn-type":[{"value":"1932-6203","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,7,11]]}}}